{"data":[{"accessionNo":"0001950047-26-010584","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"BETH HECHT","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":75000,"aggregateMarketValue":803250,"unitsOutstanding":182320306,"approxSaleDate":"2026-11-02","exchange":"NASDAQ","filedAt":"2026-11-02","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-009959","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"BETH HECHT","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":16666,"aggregateMarketValue":159326.96,"unitsOutstanding":182320306,"approxSaleDate":"2026-10-01","exchange":"NASDAQ","filedAt":"2026-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-009839","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"KEVIN MCCULLOCH","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":70000,"aggregateMarketValue":637000,"unitsOutstanding":182320306,"approxSaleDate":"2026-09-28","exchange":"NASDAQ","filedAt":"2026-09-28","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-008033","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS INC","ticker":"XERS","personName":"STEVEN PIEPER","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20000,"aggregateMarketValue":167800,"unitsOutstanding":182320306,"approxSaleDate":"2026-08-12","exchange":"NASDAQ","filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-006941","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"STEVEN PIEPER","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":27600,"aggregateMarketValue":231012,"unitsOutstanding":172642055,"approxSaleDate":"2026-07-07","exchange":"NASDAQ","filedAt":"2026-07-07","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-006884","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"STEVEN PIEPER","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":17400,"aggregateMarketValue":144072,"unitsOutstanding":172642055,"approxSaleDate":"2026-07-06","exchange":"NASDAQ","filedAt":"2026-07-06","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-006705","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"KEVIN MCCULLOCH","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":120000,"aggregateMarketValue":950400,"unitsOutstanding":172642055,"approxSaleDate":"2026-07-01","exchange":"NASDAQ","filedAt":"2026-07-01","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-006741","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"BETH HECHT","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":49998,"aggregateMarketValue":395984.16,"unitsOutstanding":172642055,"approxSaleDate":"2026-07-01","exchange":"NASDAQ","filedAt":"2026-07-01","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-005663","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"JOHN H JOHNSON","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":15000,"aggregateMarketValue":88350,"unitsOutstanding":172642055,"approxSaleDate":"2026-06-04","exchange":"NASDAQ","filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-005664","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"DAWN HALKUFF","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20000,"aggregateMarketValue":117800,"unitsOutstanding":172642055,"approxSaleDate":"2026-06-04","exchange":"NASDAQ","filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-005661","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"Barbara-Jean Bormann-Kennedy","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":16000,"aggregateMarketValue":94240,"unitsOutstanding":172642055,"approxSaleDate":"2026-06-04","exchange":"NASDAQ","filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-005565","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"MARLA PERSKY","relationship":"Director","securityClass":"COMMON","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":15500,"aggregateMarketValue":93000,"unitsOutstanding":172642055,"approxSaleDate":"2026-06-03","exchange":"NASDAQ","filedAt":"2026-06-03","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-003075","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"JAMES BRADY","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10834,"aggregateMarketValue":58503.6,"unitsOutstanding":172431290,"approxSaleDate":"2026-03-30","exchange":"NASDAQ","filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-002003","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"BETH HECHT","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":66668,"aggregateMarketValue":408008.16,"unitsOutstanding":165924289,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-26-000273","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS INC","ticker":"XERS","personName":"KEVIN MCCULLOCH","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":60000,"aggregateMarketValue":432600,"unitsOutstanding":165924289,"approxSaleDate":"2026-01-08","exchange":"NASDAQ","filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-25-010581","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"JOHN H JOHNSON","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":135402,"aggregateMarketValue":977033.75,"unitsOutstanding":165924289,"approxSaleDate":"2025-12-19","exchange":"NASDAQ","filedAt":"2025-12-19","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-25-010215","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"BARBARA-JEAN A BORMANN-KENNEDY","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":15000,"aggregateMarketValue":105150,"unitsOutstanding":165924289,"approxSaleDate":"2025-12-12","exchange":"NASDAQ","filedAt":"2025-12-12","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-25-008827","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"JOHN SHANNON","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":48149,"aggregateMarketValue":365450.91,"unitsOutstanding":165924289,"approxSaleDate":"2025-11-13","exchange":"NASDAQ","filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/xers"},{"accessionNo":"0001950047-25-008678","issuerCik":"0001867096","issuerName":"XERIS BIOPHARMA HOLDINGS, INC.","ticker":"XERS","personName":"BETH HECHT","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":66668,"aggregateMarketValue":514676.96,"unitsOutstanding":165924289,"approxSaleDate":"2025-11-11","exchange":"NASDAQ","filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/xers"}],"updatedAt":"2026-11-05T17:26:34.056Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/xers","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}